Seiji Nagano

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19

Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Targeted introduction of T cell receptor genes at the TRAC locus in cytotoxic T lymphocytes regenerated from human iPSCs by genome editing.

Targeted introduction of T cell receptor genes at the TRAC locus in cytotoxic T lymphocytes regenerated from human iPSCs by genome editing.

Journal: Biochemical and biophysical research communications

Published: March 12, 2026

Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.

Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.

Journal: Cancer immunology, immunotherapy : CII

Published: August 14, 2025

Development of off-the-shelf universal T cell therapies from ES/iPS cells: applications in cancer and viral infection

Development of off-the-shelf universal T cell therapies from ES/iPS cells: applications in cancer and viral infection

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 02, 2024

Distinct cytokines regulate gene expression and anti-tumor activity in regenerated CD8+ T cells from induced pluripotent stem cells.

Distinct cytokines regulate gene expression and anti-tumor activity in regenerated CD8+ T cells from induced pluripotent stem cells.

Journal: iScience

Published: June 04, 2024

Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem Cells.

Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem Cells.

Journal: Advances in experimental medicine and biology

Published: March 12, 2024

Development of "Off the Shelf" T Cells for Cancer Immunotherapy

Development of "Off the Shelf" T Cells for Cancer Immunotherapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 23, 2023

Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model.

Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model.

Journal: Molecular therapy oncolytics

Published: September 13, 2021

Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology.

Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology.

Journal: International immunology

Published: August 10, 2021

Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes.

Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes.

Journal: Molecular therapy. Methods & clinical development

Published: February 17, 2020

Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings

Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 22, 2019

Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model.

Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model.

Journal: iScience

Published: October 30, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026